necitumumab
Showing 1 - 15 of 15
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7
Active, not recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +2 more
- Necitumumab
- Osimertinib
-
Duarte, California
- +14 more
Jan 27, 2023
Metastatic Lung Non-Small Cell Carcinoma, Refractory Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer American Joint
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +4 more
- Necitumumab
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jan 5, 2023
Carcinoma, NSCLC (NSCLC) Trial in Orlando (Necitumumab, Nab-Paclitaxel, Carboplatin)
Completed
- Carcinoma, Non-Small Cell Lung Cancer (NSCLC)
- Necitumumab
- +2 more
-
Orlando, FloridaFlorida Hospital Cancer Institute
Oct 30, 2020
Non Small Cell Lung Cancer Trial in Worldwide (Pemetrexed, Cisplatin, Necitumumab)
Non Small Cell Lung Cancer Trial in Worldwide (Necitumumab, Gemcitabine, Cisplatin)
Active, not recruiting
- Non Small Cell Lung Cancer
- Necitumumab
- +2 more
-
Chandler, Arizona
- +181 more
Feb 4, 2022
Stage IV NSCLC Trial in Worldwide (Necitumumab, Pembrolizumab)
Completed
- Stage IV Non-Small Cell Lung Cancer
- Necitumumab
- Pembrolizumab
-
Fort Myers, Florida
- +15 more
Sep 11, 2020
Squamous Cell Carcinoma Trial in El Segundo (drug, biological, procedure)
Unknown status
- Squamous Cell Carcinoma
- Aldoxorubicin HCl
- +20 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Aug 10, 2020
NSCLC, Tumor Metastasis Trial in Belgium, France, Spain (Necitumumab, Abemaciclib)
Completed
- Carcinoma, Non-Small-Cell Lung
- Neoplasm Metastasis
- Necitumumab
- Abemaciclib
-
Charleroi, Belgium
- +14 more
Jun 26, 2020
Malignant Solid Tumor Trial in United States (Necitumumab, Gemcitabine, Cisplatin)
Completed
- Malignant Solid Tumor
- Necitumumab
- +2 more
-
Scottsdale, Arizona
- +3 more
Sep 10, 2019
Squamous NSCLC Trial in Japan (Necitumumab, Gemcitabine, Cisplatin)
Completed
- Squamous Non-small Cell Lung Cancer
- Necitumumab
- +2 more
-
Aichi, Japan
- +19 more
Oct 11, 2019
Locally Advanced Squamous NSCLC, Metastatic Squamous NSCLC Trial in Worldwide (Necitumumab, Gemcitabine, Carboplatin)
Withdrawn
- Locally Advanced Squamous Non-Small Cell Lung Cancer
- Metastatic Squamous Non-Small Cell Lung Cancer
- Necitumumab
- +2 more
-
Edina, Minnesota
- +18 more
Sep 25, 2019
Squamous Non Small Cell Lung Cancer Trial in Worldwide (Necitumumab, Paclitaxel, Carboplatin)
Completed
- Squamous Non Small Cell Lung Cancer
- Necitumumab
- +2 more
-
Jonesboro, Arkansas
- +50 more
Sep 5, 2019
NSCLC Trial in Worldwide (Necitumumab, Gemcitabine, Cisplatin)
Completed
- Non-small Cell Lung Cancer
- Necitumumab
- +2 more
-
Birmingham, Alabama
- +16 more
May 20, 2016